Clinical Trial Update: DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial update for DRIVESHAFT assessing darunavir/ritonavir in virologically suppressed HIV-infected experienced subjects; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: Ruth M. Rothstein CORE Center | Conditions: HIV | Phase 4 | Status: COMPLETED | Results posted: 2018-02-07